Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Harwood

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Pharmacology|February 1, 1990
Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell linesR L Blakley, F C Harwood, K D Huff
Biochemical Pharmacology|May 25, 1993
Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug actionJ Sosinski, J H Thakar, G S Germain, et al.
Molecular Pharmacology|September 1, 1993
Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cellsJ K Horton, K N Thimmaiah, F C Harwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemiaV M Santana, J Mirro, F C Harwood, et al.
Cancer Research|September 15, 1989
Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in miceT L Avery, J E Rehg, W C Lumm, et al.
Molecular Pharmacology|May 1, 1994
Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)ureaJ Sosinski, J H Thakar, G S Germain, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cellsK N Thimmaiah, J K Horton, R Seshadri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibitionL Dudkin, M B Dilling, P J Cheshire, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Pharmacology|February 1, 1990
Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell linesR L Blakley, F C Harwood, K D Huff
Biochemical Pharmacology|May 25, 1993
Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug actionJ Sosinski, J H Thakar, G S Germain, et al.
Molecular Pharmacology|September 1, 1993
Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cellsJ K Horton, K N Thimmaiah, F C Harwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemiaV M Santana, J Mirro, F C Harwood, et al.
Cancer Research|September 15, 1989
Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in miceT L Avery, J E Rehg, W C Lumm, et al.
Molecular Pharmacology|May 1, 1994
Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)ureaJ Sosinski, J H Thakar, G S Germain, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cellsK N Thimmaiah, J K Horton, R Seshadri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibitionL Dudkin, M B Dilling, P J Cheshire, et al.
Pageof 1